How much funding has Zephyr AI raised?

Zephyr AI has raised $111.0M in total funding, most recently a Series A round.

Who are Zephyr AI's investors?

Zephyr AI's investors include Revolution Growth, Eli Lilly & Company, Jeff Skoll, EPIQ Capital Group.

Where is Zephyr AI headquartered?

Zephyr AI is headquartered in McLean, Virginia, United States.

What industry is Zephyr AI in?

Zephyr AI operates in Artificial Intelligence, Healthcare.

Zephyr AI

Precision Medicine Powered by AI

McLean, United States · Founded 2020 · $111.0M raised

Artificial Intelligence

Healthcare

Headquarters: McLean, Virginia
Employees: 11–50
Founded: 2020
Business Model: B2B

Website: zephyrai.bio
Total Funding: $111.0M
Last Round: $111.0M Series AMar 2024
Rounds: 1

About

Zephyr AI is a high-growth healthcare technology company transforming real-world data into actionable insights for drug discovery and diagnostics. Using large complex data and proprietary algorithms, it delivers explainable AI-enabled precision medicine solutions for oncology and cardiometabolic disease, serving biopharma and healthcare partners.

Summary

Zephyr AI is an Artificial Intelligence company based in McLean, United States, founded in 2020. It has raised $111.0M in total across 1 round, most recently a $111.0M Series A round in Mar 2024. Investors include Revolution Growth, Eli Lilly & Company and Jeff Skoll.